Gregg Lapointe - May 19, 2021 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role: Director
Signature: /s/ Dolly Vance (Attorney-in-Fact)
Stock symbol: RIGL
Transactions as of: May 19, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/21/2021, 08:55 PM
Next filing: Jun 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RIGL	Common Stock	Award	$0	+25K		$0.00	25K	May 19, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RIGL	Stock Option (Right to Buy)	Award	$0	+30K		$0.00	30K	May 19, 2021	Common Stock	30K	$3.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors.
F2	The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors.